Trial Search Results
Pharmacokinetics of Ketamine in Infants and Children
Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.
Stanford is currently not accepting patients for this trial.
Collaborator: University of Colorado, Denver
- Drug: ketamine hydrochloride
- Term infants (38 weeks gestation)and infants and children up to age 18 years.
- Patients who require procedures that necessitate at least 8 hours in the hospital and
those being admitted after procedure will be eligible to participate.
- Patients who will receive ketamine as part of their standard anesthesia regimen.
- Preterm neonates
- Liver Disease
- Kidney disease
- Heart failure
- Patients receiving anticonvulsants or barbiturates
Ages Eligible for Study
N/A - 17 Years
Genders Eligible for Study